Abstract: Pressure sensitive adhesive compositions comprising an unreactive mixture of polydiorganosiloxane polyurea copolymer, diluent, and silicate tackifying resin. The compositions are useful for articles such as medical devices.

Abstract: Pressure sensitive adhesive compositions comprising an unreactive mixture of polydiorganosiloxane polyurea copolymer, diluent, and silicate tackifying resin. The compositions are useful for articles such as medical devices.

Abstract: A method for treatment or prevention of skin lesions, e.g., blisters, comprising: a) applying a liquid polymerizable foundation composition to a selected location on skin, e.g., an existing lesion or an area to be protected from formation of a lesion, b) at least partially polymerizing the foundation composition in situ to form a foundation layer, and c) applying a liquid cap formulation to the foundation layer. Also a kit for carrying out such method.

Abstract: A device for treatment of plantar fasciitis and/or Achilles tendonitis that comprises: (a) a calf strap removably engagable to the calf of a leg; (b) a foot assembly removably engagable to the foot of the leg such that when the device is worn the assembly can be positioned proximate to the ball of the foot intermediate to the midfoot and forefoot areas of the foot to secure it to the foot; and (c) a substantially inelastic tension member connectable between the calf strap and the foot assembly in a tensioned manner such that when the device is worn the plantarflexion of the ankle is limited such that the plantar surface of the foot is held in a neutral to slight dorsiflection. Also, a method of treating plantar fasciitis and/or Achilles tendonitis that comprises applying a such a device so as to maintain the plantar fascia and other structures on the plantar surface of the foot in a neutral to slight dorsiflection.

Abstract: Antiviral compositions, especially those useful when applied topically, particularly to mucosal tissues (i.e., mucous membranes), including, in particular, an antiviral lipid component, such as a fatty acid ester, fatty ether, or alkoxide derivative thereof, and an organoleptic neutralizing agent. Such compositions provide effective topical antimicrobial activity and are accordingly useful in the treatment and/or prevention of conditions that are caused, or aggravated by, microorganisms (including viruses).

Abstract: Methods and systems for closing wounds using wound closures and a flowable adhesive skin paint are disclosed. The flowable adhesive does not adhere the wound closures to the skin over the wound to reduce irritation. In some embodiments, the skin paint may include 1-40% of a siloxane-containing polymer; 60-99% of an Alkane-Based Siloxane Polymer Reaction Solvent; and 0-15% of adjuvants. The wound closures used with such a skin paint may include a wound bridging portion of microporous polypropylene film.

Abstract: Pressure sensitive adhesive articles and methods, particularly stretch removable adhesive articles that are preferably for use in adhering to skin or like delicate surfaces. Preferably, stretch removability of the article occurs as a result of the selection of a stretch removable pressure sensitive adhesive. In one embodiment of the articles and methods, the adhesive and backing delaminate upon removal. In another embodiment of the articles and methods, the backing includes a predefined tab located in a central location of the backing.

Abstract: A wound closure including a wound bridging portion that has sufficient dimensional stability to hold the wound edges in proper alignment, even in the face of substantial stretching of the wound closure as a whole, is disclosed. The wound closure is dimensionally stable directly over the wound. The remainder of the wound closure is preferably substantially more extensible and elastic than the wound bridging portion to improve conformability and adhesion of the wound closure to the patient. The wound closures may include opposing end portions of unequal lengths yielding an asymmetric shape that facilitates close placement of the wound closures along a wound.

Abstract: This invention is directed to a reinforced adhesive fiber that includes a pressure sensitive adhesive component and a reinforcing material within the pressure sensitive adhesive component.

Abstract: Methods and systems for closing wounds using wound closures and a flowable adhesive skin paint are disclosed. The flowable adhesive does not adhere the wound closures to the skin over the wound to reduce irritation. In some embodiments, the skin paint may include 1-40% of a siloxane-containing polymer; 60-99% of an Alkane-Based Siloxane Polymer Reaction Solvent; and 0-15% of adjuvants. The wound closures used with such a skin paint may include a wound bridging portion of microporous polypropylene film.